rs2289541

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001366385.1(CARD14):​c.2648G>A​(p.Arg883His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00311 in 1,566,766 control chromosomes in the GnomAD database, including 205 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 183 hom. )

Consequence

CARD14
NM_001366385.1 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.22

Publications

10 publications found
Variant links:
Genes affected
CARD14 (HGNC:16446): (caspase recruitment domain family member 14) This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
SGSH (HGNC:10818): (N-sulfoglucosamine sulfohydrolase) This gene encodes the enzyme sulfamidase; one of several enzymes involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with the lysosomal storage disease mucopolysaccaridosis IIIA, also known as Sanfilippo syndrome A, which results from impaired degradation of heparan sulfate. Transcripts of varying sizes have been reported but their biological validity has not been determined. [provided by RefSeq, Jun 2017]
SGSH Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 3A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Orphanet, Myriad Women’s Health, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016128719).
BP6
Variant 17-80205609-G-A is Benign according to our data. Variant chr17-80205609-G-A is described in ClinVar as Benign. ClinVar VariationId is 458097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.08 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD14NM_001366385.1 linkc.2648G>A p.Arg883His missense_variant Exon 22 of 24 ENST00000648509.2 NP_001353314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD14ENST00000648509.2 linkc.2648G>A p.Arg883His missense_variant Exon 22 of 24 NM_001366385.1 ENSP00000498071.1 Q9BXL6-1

Frequencies

GnomAD3 genomes
AF:
0.00371
AC:
564
AN:
152106
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00164
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.0864
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00751
AC:
1309
AN:
174330
AF XY:
0.00735
show subpopulations
Gnomad AFR exome
AF:
0.00184
Gnomad AMR exome
AF:
0.000379
Gnomad ASJ exome
AF:
0.000468
Gnomad EAS exome
AF:
0.0869
Gnomad FIN exome
AF:
0.000188
Gnomad NFE exome
AF:
0.000225
Gnomad OTH exome
AF:
0.00532
GnomAD4 exome
AF:
0.00305
AC:
4313
AN:
1414542
Hom.:
183
Cov.:
34
AF XY:
0.00304
AC XY:
2128
AN XY:
699172
show subpopulations
African (AFR)
AF:
0.000737
AC:
24
AN:
32548
American (AMR)
AF:
0.000345
AC:
13
AN:
37674
Ashkenazi Jewish (ASJ)
AF:
0.000636
AC:
16
AN:
25176
East Asian (EAS)
AF:
0.0919
AC:
3440
AN:
37416
South Asian (SAS)
AF:
0.00307
AC:
247
AN:
80470
European-Finnish (FIN)
AF:
0.000100
AC:
5
AN:
50010
Middle Eastern (MID)
AF:
0.00143
AC:
8
AN:
5590
European-Non Finnish (NFE)
AF:
0.000131
AC:
142
AN:
1087144
Other (OTH)
AF:
0.00714
AC:
418
AN:
58514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
194
389
583
778
972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00371
AC:
564
AN:
152224
Hom.:
22
Cov.:
32
AF XY:
0.00406
AC XY:
302
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00164
AC:
68
AN:
41548
American (AMR)
AF:
0.000458
AC:
7
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.0866
AC:
447
AN:
5160
South Asian (SAS)
AF:
0.00559
AC:
27
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68004
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
26
52
78
104
130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00221
Hom.:
55
Bravo
AF:
0.00416
ESP6500AA
AF:
0.00274
AC:
12
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00545
AC:
647
Asia WGS
AF:
0.0510
AC:
176
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pityriasis rubra pilaris;C1864497:Psoriasis 2 Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32199921) -

Autoinflammatory syndrome Benign:1
Mar 11, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.051
DANN
Benign
0.87
DEOGEN2
Benign
0.0022
T;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0057
N
LIST_S2
Benign
0.53
.;.;T
MetaRNN
Benign
0.0016
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.27
N;N;N
PhyloP100
-1.2
PrimateAI
Benign
0.22
T
PROVEAN
Benign
0.80
.;.;N
REVEL
Benign
0.041
Sift
Benign
0.53
.;.;T
Sift4G
Benign
0.43
T;.;T
Polyphen
0.0
B;B;B
Vest4
0.034
MVP
0.31
MPC
0.18
ClinPred
0.0019
T
GERP RS
-8.8
Varity_R
0.027
gMVP
0.41
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2289541; hg19: chr17-78179408; COSMIC: COSV58339402; COSMIC: COSV58339402; API